Resectable Pancreatic Head Cancer
Resectable pancreatic head cancer is a type of cancer located in the head of the pancreas that can be surgically removed. Early detection and treatment are crucial for better outcomes.
Pancreatic Head Cancer: Neoadjuvant Chemotherapy Study
We are exploring whether giving chemotherapy before surgery helps improve survival for patients with resectable pancreatic head cancer compared to surgery alone. This study aims to find better treatment strategies to reduce early mortality.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have any other cancers in the past 5 years, except for non-melanomatous skin cancer or non-invasive cervical cancer?
- Do you have any serious health problems that would prevent you from having major surgery?
- Are you currently pregnant, breastfeeding, or not using effective birth control if you can become pregnant?
- Is your serum creatinine (kidney function marker from blood test) higher than 1.5?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Antrex
Buateron
Calcifolin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Haukeland University Hospital
Department of Gastrointestinal Surgery
Bergen, Norway
Oslo University Hospital HF
Department of Hepato Pancreato Biliary Surgery
Oslo, Norway
Helse Stavanger HF
Department of Gastrointestinal Surgery
Stavanger, Norway
Sponsor: Oslo University Hospital HF
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.